Sunshine Heart (SSH)
shares have taken a beating since their fall 2013 peak, falling about
60% from their peak on a combination of slow pivotal trial enrollment
and a sharp turn away from risky, speculative health care stocks. With
Sunshine Heart due to report results tomorrow (May 13), it is a safe bet
that investors will be keenly focused on the enrollment figures for the
COUNTER-HF study, even though it may be too optimistic to assume that
the company's awareness efforts have had a major impact at this point.
Read more here:
Will Sunshine Heart Get Schooled If Enrollment Disappoints Again?
No comments:
Post a Comment